Clinical trial

A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of the Dayspring Technology for Patients With Breast Cancer Related Lymphedema (BCRL) After Lymphatic Surgery

NCT04888975

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2021-06-01

PhaseNA

Study timeline

Study start (estimated)2021-06-01Date precision: day

Registry last updated2021-05-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Lymphedemaunresolved

Lymphedema, Breast Cancerunresolved

Lymphedema Armunresolved

Interventions

Dayspring Active Wearable Compression SystemDEVICE

Sponsors & collaborators

Koya Medical, Inc.lead sponsor

Mapped research locations

Palo AltoCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04888975 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.